Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the nine months ended September 30, 2020. Clinical Developments and Corporate Highlights for the Third Quarter and Recent Weeks Include: Positive Interim…
Details